Detection of Immunotoxic Gluten Peptides in Feces
CELIQK2
Phase 0 Monitoring of Gluten-free Diet Compliance in Celiac Patients by Assessment of Gliadin 33-mer Equivalent Epitopes in Feces
1 other identifier
observational
53
1 country
1
Brief Summary
The purpose of this study is to monitor of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 21, 2011
CompletedFirst Posted
Study publicly available on registry
November 23, 2011
CompletedNovember 24, 2011
November 1, 2011
November 21, 2011
November 23, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Monitoring of gluten-free diet compliance in celiac patients
Usual gluten diet for celiac (home diet not modified for this trial)
April-July 2011 (3 months)
Study Arms (1)
Celiac patients
Interventions
Detection of Gluten in Feces
Eligibility Criteria
Celiac patients, 1-12 years old
You may qualify if:
- Celiac patient
- years old
- Written informed consent
You may not qualify if:
- Known inflammatory bowel diseases
- Participation in any other studies involving investigational concomitantly or within two weeks prior to entry into the study and during the course of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Microbiology and Parasitology, Faculty of Pharmacy, University of Seville
Seville, Seville, 41012, Spain
Related Publications (5)
Moron B, Cebolla A, Manyani H, Alvarez-Maqueda M, Megias M, Thomas Mdel C, Lopez MC, Sousa C. Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide. Am J Clin Nutr. 2008 Feb;87(2):405-14. doi: 10.1093/ajcn/87.2.405.
PMID: 18258632BACKGROUNDMoron B, Bethune MT, Comino I, Manyani H, Ferragud M, Lopez MC, Cebolla A, Khosla C, Sousa C. Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One. 2008 May 28;3(5):e2294. doi: 10.1371/journal.pone.0002294.
PMID: 18509534BACKGROUNDHausch F, Shan L, Santiago NA, Gray GM, Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol. 2002 Oct;283(4):G996-G1003. doi: 10.1152/ajpgi.00136.2002.
PMID: 12223360BACKGROUNDShan L, Molberg O, Parrot I, Hausch F, Filiz F, Gray GM, Sollid LM, Khosla C. Structural basis for gluten intolerance in celiac sprue. Science. 2002 Sep 27;297(5590):2275-9. doi: 10.1126/science.1074129.
PMID: 12351792BACKGROUNDComino I, Real A, Vivas S, Siglez MA, Caminero A, Nistal E, Casqueiro J, Rodriguez-Herrera A, Cebolla A, Sousa C. Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces. Am J Clin Nutr. 2012 Mar;95(3):670-7. doi: 10.3945/ajcn.111.026708. Epub 2012 Jan 18.
PMID: 22258271DERIVED
Biospecimen
Fecal samples
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carolina Sousa, Professor
University of Seville, Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 21, 2011
First Posted
November 23, 2011
Study Start
April 1, 2011
Study Completion
July 1, 2011
Last Updated
November 24, 2011
Record last verified: 2011-11